Rejecting ICER ’s bad advice
America leads the world in biomedical innovation today because our system rewards investment in research and discovery of new treatments. Now, with the passage of theInflation Reduction Act, Dr. Steven Pearson, president of the Institute for Clinical and Economic Review (ICER), coolly admits we will see fewer new cures and treatments and suggests that trade-off is one we need to make.
Source: The Catalyst - Category: Pharmaceuticals Authors: Priscilla VanderVeer Tags: Government Price Setting Source Type: news
More News: Government | Pharmaceuticals